JohnBoy2000
Bluelighter
- Joined
- May 11, 2016
- Messages
- 2,596
2.5 Pharmacokinetics and metabolism
Apart from its binding to MC1R, afamelanotide binds weakly to MC3R and MC4R [50], which mainly are expressed in the gastrointestinal system and CNS, respectively. The inability of afamelanotide to penetrate the blood--brain barrier after systemic application prevents the activation of these receptors [51,52], and no anorexia or sexual stimulation is reported after application of therapeutic doses.
Again, who knows, really?
.......
Reference 51:
Is a laughable read.
.......
Reference 52:
Carries little actual information on the claim.